A

Amyriad Therapeutics

7 employees

Operator of a clinical-stage biopharmaceutical company intended to develop therapies for the relief of Alzheimer's disease symptoms.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2019

Funding rounds raised

A

Amyriad Therapeutics raised undisclosed on November 27, 2022

Investors: infinitas capital

FAQ